Cargando…

Transcutaneous vaccination via laser microporation

Driven by constantly increasing knowledge about skin immunology, vaccine delivery via the cutaneous route has recently gained renewed interest. Considering its richness in immunocompetent cells, targeting antigens to the skin is considered to be more effective than intramuscular or subcutaneous inje...

Descripción completa

Detalles Bibliográficos
Autores principales: Weiss, Richard, Hessenberger, Michael, Kitzmüller, Sophie, Bach, Doris, Weinberger, Esther E., Krautgartner, Wolf D., Hauser-Kronberger, Cornelia, Malissen, Bernard, Boehler, Christof, Kalia, Yogeshvar N., Thalhamer, Josef, Scheiblhofer, Sandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science Publishers 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3462999/
https://www.ncbi.nlm.nih.gov/pubmed/22750193
http://dx.doi.org/10.1016/j.jconrel.2012.06.031
_version_ 1782245237654028288
author Weiss, Richard
Hessenberger, Michael
Kitzmüller, Sophie
Bach, Doris
Weinberger, Esther E.
Krautgartner, Wolf D.
Hauser-Kronberger, Cornelia
Malissen, Bernard
Boehler, Christof
Kalia, Yogeshvar N.
Thalhamer, Josef
Scheiblhofer, Sandra
author_facet Weiss, Richard
Hessenberger, Michael
Kitzmüller, Sophie
Bach, Doris
Weinberger, Esther E.
Krautgartner, Wolf D.
Hauser-Kronberger, Cornelia
Malissen, Bernard
Boehler, Christof
Kalia, Yogeshvar N.
Thalhamer, Josef
Scheiblhofer, Sandra
author_sort Weiss, Richard
collection PubMed
description Driven by constantly increasing knowledge about skin immunology, vaccine delivery via the cutaneous route has recently gained renewed interest. Considering its richness in immunocompetent cells, targeting antigens to the skin is considered to be more effective than intramuscular or subcutaneous injections. However, circumvention of the superficial layer of the skin, the stratum corneum, represents the major challenge for cutaneous immunization. An optimal delivery method has to be effective and reliable, but also highly adaptable to specific demands, should avoid the use of hypodermic needles and the requirement of specially trained healthcare workers. The P.L.E.A.S.E.® (Precise Laser Epidermal System) device employed in this study for creation of aqueous micropores in the skin fulfills these prerequisites by combining the precision of its laser scanning technology with the flexibility to vary the number, density and the depth of the micropores in a user-friendly manner. We investigated the potential of transcutaneous immunization via laser-generated micropores for induction of specific immune responses and compared the outcomes to conventional subcutaneous injection. By targeting different layers of the skin we were able to bias polarization of T cells, which could be modulated by addition of adjuvants. The P.L.E.A.S.E.® device represents a highly effective and versatile platform for transcutaneous vaccination.
format Online
Article
Text
id pubmed-3462999
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Elsevier Science Publishers
record_format MEDLINE/PubMed
spelling pubmed-34629992012-10-19 Transcutaneous vaccination via laser microporation Weiss, Richard Hessenberger, Michael Kitzmüller, Sophie Bach, Doris Weinberger, Esther E. Krautgartner, Wolf D. Hauser-Kronberger, Cornelia Malissen, Bernard Boehler, Christof Kalia, Yogeshvar N. Thalhamer, Josef Scheiblhofer, Sandra J Control Release Article Driven by constantly increasing knowledge about skin immunology, vaccine delivery via the cutaneous route has recently gained renewed interest. Considering its richness in immunocompetent cells, targeting antigens to the skin is considered to be more effective than intramuscular or subcutaneous injections. However, circumvention of the superficial layer of the skin, the stratum corneum, represents the major challenge for cutaneous immunization. An optimal delivery method has to be effective and reliable, but also highly adaptable to specific demands, should avoid the use of hypodermic needles and the requirement of specially trained healthcare workers. The P.L.E.A.S.E.® (Precise Laser Epidermal System) device employed in this study for creation of aqueous micropores in the skin fulfills these prerequisites by combining the precision of its laser scanning technology with the flexibility to vary the number, density and the depth of the micropores in a user-friendly manner. We investigated the potential of transcutaneous immunization via laser-generated micropores for induction of specific immune responses and compared the outcomes to conventional subcutaneous injection. By targeting different layers of the skin we were able to bias polarization of T cells, which could be modulated by addition of adjuvants. The P.L.E.A.S.E.® device represents a highly effective and versatile platform for transcutaneous vaccination. Elsevier Science Publishers 2012-09-10 /pmc/articles/PMC3462999/ /pubmed/22750193 http://dx.doi.org/10.1016/j.jconrel.2012.06.031 Text en © 2012 Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/3.0/ Open Access under CC BY-NC-ND 3.0 (https://creativecommons.org/licenses/by-nc-nd/3.0/) license
spellingShingle Article
Weiss, Richard
Hessenberger, Michael
Kitzmüller, Sophie
Bach, Doris
Weinberger, Esther E.
Krautgartner, Wolf D.
Hauser-Kronberger, Cornelia
Malissen, Bernard
Boehler, Christof
Kalia, Yogeshvar N.
Thalhamer, Josef
Scheiblhofer, Sandra
Transcutaneous vaccination via laser microporation
title Transcutaneous vaccination via laser microporation
title_full Transcutaneous vaccination via laser microporation
title_fullStr Transcutaneous vaccination via laser microporation
title_full_unstemmed Transcutaneous vaccination via laser microporation
title_short Transcutaneous vaccination via laser microporation
title_sort transcutaneous vaccination via laser microporation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3462999/
https://www.ncbi.nlm.nih.gov/pubmed/22750193
http://dx.doi.org/10.1016/j.jconrel.2012.06.031
work_keys_str_mv AT weissrichard transcutaneousvaccinationvialasermicroporation
AT hessenbergermichael transcutaneousvaccinationvialasermicroporation
AT kitzmullersophie transcutaneousvaccinationvialasermicroporation
AT bachdoris transcutaneousvaccinationvialasermicroporation
AT weinbergeresthere transcutaneousvaccinationvialasermicroporation
AT krautgartnerwolfd transcutaneousvaccinationvialasermicroporation
AT hauserkronbergercornelia transcutaneousvaccinationvialasermicroporation
AT malissenbernard transcutaneousvaccinationvialasermicroporation
AT boehlerchristof transcutaneousvaccinationvialasermicroporation
AT kaliayogeshvarn transcutaneousvaccinationvialasermicroporation
AT thalhamerjosef transcutaneousvaccinationvialasermicroporation
AT scheiblhofersandra transcutaneousvaccinationvialasermicroporation